ORIC PHARMACEUTICALS INC. - COMMON STOCK

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

03 11月 2023 15:30:00 条件 Nasdaq GlobeNewswire

ORIC Pharmaceuticals to Present Initial Phase 1b Clinical Data for ORIC-533 in Multiple Myeloma at the 65th American Society of Hematology (ASH) Annual Meeting

02 11月 2023 08:00:00 条件 Nasdaq GlobeNewswire

Initial Phase 1 Dose Escalation Data of ORIC-114 in Patients with EGFR and HER2 Exon 20 Mutations Demonstrates Potential Best-In-Class Profile

21 10月 2023 06:30:00 条件 Nasdaq GlobeNewswire

ORIC Pharmaceuticals to Present Initial Phase 1b Clinical Data for ORIC 114 in EGFR/HER2 Exon 20 Mutated NSCLC at the European Society of Medical Oncology (ESMO) Congress 2023

17 10月 2023 15:30:00 条件 Nasdaq GlobeNewswire

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

06 10月 2023 15:30:00 条件 Nasdaq GlobeNewswire

ORIC Pharmaceuticals to Participate in the 2023 Cantor Global Healthcare Conference

20 9月 2023 15:30:00 条件 Nasdaq GlobeNewswire

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

01 9月 2023 15:30:00 条件 Nasdaq GlobeNewswire

ORIC Pharmaceuticals to Participate in Upcoming Investor Conferences

30 8月 2023 15:30:00 条件 Nasdaq GlobeNewswire

ORIC Pharmaceuticals Reports Second Quarter 2023 Financial Results and Operational Updates

10 8月 2023 15:05:03 条件 Nasdaq GlobeNewswire

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

04 8月 2023 15:30:00 条件 Nasdaq GlobeNewswire

ORIC Pharmaceuticals Announces $85 Million Private Placement Financing

26 6月 2023 07:30:00 条件 Nasdaq GlobeNewswire

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

02 6月 2023 15:15:00 条件 Nasdaq GlobeNewswire

ORIC Pharmaceuticals to Participate in the Jefferies Healthcare Conference

31 5月 2023 15:10:00 条件 Nasdaq GlobeNewswire

ORIC Pharmaceuticals Reports First Quarter 2023 Financial Results and Operational Updates

08 5月 2023 15:05:00 条件 Nasdaq GlobeNewswire

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

05 5月 2023 15:15:00 条件 Nasdaq GlobeNewswire

ORIC Pharmaceuticals to Participate in the H.C. Wainwright BioConnect Investor Conference

25 4月 2023 15:30:00 条件 Nasdaq GlobeNewswire

ORIC Pharmaceuticals Presents Promising Preclinical Data on Two Programs at the 2023 American Association for Cancer Research (AACR) Annual Meeting

18 4月 2023 15:15:00 条件 Nasdaq GlobeNewswire

ORIC Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Operational Updates

16 3月 2023 15:05:00 条件 Nasdaq GlobeNewswire

ORIC Pharmaceuticals Announces Multiple Presentations at the 2023 American Association for Cancer Research (AACR) Annual Meeting

14 3月 2023 15:30:00 条件 Nasdaq GlobeNewswire

ORIC Pharmaceuticals to Participate in the Oppenheimer 33rd Annual Healthcare Conference

06 3月 2023 15:15:00 条件 Nasdaq GlobeNewswire